DivIVA proteins are curvature-sensitive membrane binding proteins that recruit other proteins to the poles and the division septum. They consist of a conserved N-terminal lipid binding domain fused to a less conserved C-terminal domain. DivIVA homologues interact with different proteins involved in cell division, chromosome segregation, genetic competence, or cell wall synthesis. It is unknown how DivIVA interacts with these proteins, and we used the interaction of Bacillus subtilis DivIVA with MinJ and RacA to investigate this. MinJ is a transmembrane protein controlling division site selection, and the DNA-binding protein RacA is crucial for chromosome segregation during sporulation. Initial bacterial two-hybrid experiments revealed that the C terminus of DivIVA appears to be important for recruiting both proteins. However, the interpretation of these results is limited since it appeared that C-terminal truncations also interfere with DivIVA oligomerization. Therefore, a chimera approach was followed, making use of the fact that Listeria monocytogenes DivIVA shows normal polar localization but is not biologically active when expressed in B. subtilis. Complementation experiments with different chimeras of B. subtilis and L. monocytogenes DivIVA suggest that MinJ and RacA bind to separate DivIVA domains. Fluorescence microscopy of green fluorescent proteintagged RacA and MinJ corroborated this conclusion and suggests that MinJ recruitment operates via the N-terminal lipid binding domain, whereas RacA interacts with the C-terminal domain. We speculate that this difference is related to the cellular compartments in which MinJ and RacA are active: the cell membrane and the cytoplasm, respectively.
D ivIVA homologues constitute a group of highly conserved cell division proteins in Gram-positive bacteria. They bind to the cytosolic face of the cytoplasmic membrane and accumulate at membrane regions with increased negative curvature in rodshaped bacteria (1) (2) (3) . Negatively curved (i.e., concave) membrane regions occur at the cell poles and along the cytokinetic ring as soon as it starts to constrict and invaginates the cell membrane. Membrane binding and curvature sensitivity appear to be intrinsic features of DivIVA, as it was shown that DivIVA of Bacillus subtilis also localizes to curved membranes when expressed in other, nonrelated species, including yeast cells (4) . DivIVA is used as a scaffold and recruits other proteins that function in cell division, cell wall biosynthesis, secretion, genetic competence, or chromosome segregation (5) (6) (7) (8) (9) (10) (11) (12) (13) . The proteins that interact with DivIVA are therefore diverse and comprise both transmembrane and cytosolic proteins (14) . The best-characterized DivIVA protein is that of B. subtilis, for which four different interaction partners are known: (i) the transmembrane protein MinJ, which acts as a molecular bridge between DivIVA and the FtsZ-inhibiting MinCD complex (11, 12) ; (ii) the DNA-binding protein RacA, which is required for chromosome segregation during spore formation (8, 15) ; (iii) the competence-specific inhibitor of cell division Maf (16) ; and (iv) the competence regulator ComN (17) . Nothing is known about the molecular interaction between DivIVA and its interaction partners. We set out to determine DivIVA interaction domains in more detail and focused on the binding of B. subtilis DivIVA with MinJ and RacA.
The crystal structure of B. subtilis DivIVA revealed a two-domain organization: a highly conserved N-terminal domain that forms a dimeric structure with a characteristic cap structure and a less conserved C-terminal domain that is rich in coiled coils but varies in length among the different bacterial species (18) . These domains are connected by a flexible ϳ20-amino-acid linker (Fig.  1) . The N-terminal domain is required for the lipid binding of DivIVA and for localization (1, 18, 19) . The dimeric cap structure of this lipid binding domain (LBD) exposes two phenylalanine side chains (F17, one per subunit), and the insertion of these side chains into the hydrophobic core of the phospholipid bilayer is essential for lipid binding (18) . This membrane interaction is stabilized by auxiliary electrostatic interactions between positively charged arginine and lysine residues (R18 and K15) in the immediate vicinity of F17 and the negatively charged phospholipid head groups (18) . The crystal structure suggested that the central coiledcoil region of the C-terminal domain contributes to DivIVA dimerization ( Fig. 1B) and that the end of this domain (amino acids 130 to 153) forms an antiparallel four-helix bundle constituting the tetramerization domain (TD) whereby two DivIVA dimers are linked together in an end-to-end orientation (18) (Fig. 1A and B ). The C-terminal part of DivIVA is the least-conserved domain; it differs in length and can contain large insertions ( Fig. 1A) . It was therefore speculated that this domain is responsible for the interaction with other proteins (14) .
To test whether the C terminus of DivIVA comprises the partner interaction domain, we tested C-terminally truncated variants of B. subtilis DivIVA for their interaction with MinJ and RacA using the bacterial two-hybrid system. These experiments proved inconclusive since removal of the tetramerization domain ap-peared to affect oligomerization. Therefore, we set up a complementation assay with chimeric DivIVA proteins that consist of domains from B. subtilis DivIVA and Listeria monocytogenes DivIVA. The latter protein localizes normally when expressed in B. subtilis but is biologically inactive and is unable to recruit MinJ or RacA to the cell division sites and cell poles. This experiment revealed that the sporulation activity and the cell division activity of DivIVA can be separated. It emerged that the transmembrane protein MinJ binds to the N-terminal lipid binding domain of DivIVA, whereas the C-terminal domain of DivIVA contains the binding site for the cytosolic protein RacA.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All bacterial strains that were used in this study are listed in Table 1 . Routinely, B. subtilis strains were cultivated in LB broth or on LB agar at 37°C. If necessary, the following antibiotics were added at the indicated concentrations: tetracycline (10 g/ml), spectinomycin (100 g/ml), and chloramphenicol (5 g/ml). Other supplements were IPTG (isopropyl-␤-D-thiogalactopyranoside; 1 mM) and xylose (0.5%). For all cloning procedures, Escherichia coli TOP10 was used as the standard plasmid host (23) .
Construction of bacterial two-hybrid plasmids. In order to construct C-terminal truncations of divIVA for use in the bacterial two-hybrid assay, plasmids p25N-divIVA and pUT18-divIVA were used as the templates in a PCR with oligonucleotide 25_N_18_F as the forward primer and the oligonucleotides divIVA_11_B2H_R (DivIVA which lacks the last 11 C-terminal amino acids [DivIVA⌬11]), divIVA_19_B2H_R (DivIVA⌬20), divIVA_21_R (DivIVA⌬21), divIVA_26_R (DivIVA⌬26), and divIVA_34_R (DivIVA⌬34) as the complementary primers (for all primer sequences, see Table 2 ). The PCR products were KpnI digested, self-ligated, and transformed to E. coli. The appropriate clones were identified using restriction analysis and DNA sequencing.
Construction of plasmids containing divIVA from B. subtilis and L. monocytogenes. For xylose-inducible expression of B. subtilis divIVA (divIVA Bs ), we constructed plasmid pSH19. This plasmid was obtained by introducing a stop codon between divIVA and gfp using plasmid pSH3 as the template and the oligonucleotides SV23/SV24 as the primers in a QuikChange mutagenesis reaction. In order to express the L. monocyto-genes divIVA (divIVA Lm ) gene in B. subtilis cells, plasmid pSH209 was constructed. This plasmid contains the complete lmo2020 open reading frame of L. monocytogenes under the control of the P xyl promoter. It was obtained by amplification of the L. monocytogenes divIVA DNA fragment with the oligonucleotides SHW109/SHW110 and subsequent cloning of the obtained fragment into plasmid pSG1154 using KpnI/XhoI. Plasmid pSH210 was constructed in the same way to allow the expression of L. monocytogenes DivIVA-green fluorescent protein (GFP) in cells of B. subtilis. However, for this cloning, the divIVA DNA fragment was amplified with primers SHW109/SHW111 to fuse the divIVA gene in frame to the gfp gene of the vector backbone. The A206K mutation, which prevents dimerization of GFP (24, 25) , was introduced into the gfp part of plasmid pSH210 using QuikChange mutagenesis with SHW425/SHW426 as the mutagenic primers. The resulting plasmid was sequenced and named pSH354.
Construction of divIVA chimeras. For the construction of chimeric divIVA genes consisting of N-terminal parts from L. monocytogenes and C-terminal parts from B. subtilis, a PCR-based restriction-free cloning strategy was used (26) . C-terminal fragments of the B. subtilis divIVA gene were amplified from plasmid pSH19 with SHW237 (pSH260), SHW238 (pSH261), SHW247 (pSH267), SHW265 (pSH272), and SHW266 (pSH278) as the respective forward primers and SHW184 as the reverse primer in a first step. All forward primers were identical to the desired fusion sites in the L. monocytogenes divIVA gene in their 5= regions, whereas the reverse primer SHW184 annealed outside the B. subtilis divIVA gene in the pSH19 plasmid backbone. For the construction of the divIVA Bs-57-Lm chimera, a DNA fragment corresponding to the first 57 amino acids of the B. subtilis divIVA gene was amplified in a PCR with pSH19 as the template and SHW354 and SHW355 as the primers. All PCR products were purified using a PCR purification kit from Qiagen and used as megaprimers in a second PCR with plasmid pSH209 as the template in order to fuse the N-and C-terminal fragments of B. subtilis divIVA to the corresponding portions of the L. monocytogenes divIVA gene. For the construction of the divIVA Bs-57-Lm chimera (pKK13), primer SHW180 was added as a reverse primer to the PCR mixture. The PCR mixtures were then DpnI digested and transformed, and the correct clones were identified using restriction analysis and DNA sequencing.
GFP was fused to all DivIVA chimeras by replacing the stop codon of the chimeric divIVA genes by a glycine codon in a way in that the divIVA (18) . Crystallographic data for the linker between both domains (residues 53 to 70) are not available. Amino acid positions at the beginning and the end of the lipid binding domain as well as the C-terminal domain are indicated for one molecule. Truncation sites of DivIVA⌬C26 and DivIVA⌬C34 at positions 138 and 130, respectively, are also shown (compare Table 3 ).
genes were fused to the downstream gfp open reading frame that was already present in these plasmids. For this purpose, we used the oligonucleotides SHW304/SHW305 to replace the divIVA stop codons in plasmids pSH260, pSH261, pSH267, pSH272, and pSH278. The replacement Finally, the gfpA206K mutation was also introduced into plasmid pSH326 as described above to result in plasmid pSH355.
Construction of a minJ-gfp fusion.
In order to express a minJ-gfp fusion in the divIVA chimera strains, the minJ-gfp allele of strain SB002 was PCR amplified using the oligonucleotides SHW342/SHW343, the resulting PCR fragment was cut with BamHI/SalI and ligated to pAPNC213cat digested with the same enzymes, and the resulting plasmid was named pSH316 after DNA sequencing. However, there was only marginal MinJ-GFP fluorescence, when pSH316 was inserted into the B. subtilis chromosome under inducing conditions (strain BSN308; data not shown). Therefore, plasmid pSH317 was constructed, in which the lacI gene of pSH316 was deleted by PCR using the primer pair SHW349/ SHW350 in order to enhance the fluorescence signal. MinJ-GFP fluorescence was still not sufficient with this allele (strain BSN317; data not shown), so the promoter region of the B. subtilis divIVA gene, including the ribosomal binding site (RBS), was amplified with primers SV98/ SHW356, and the resulting PCR fragment was cut with KpnI and XhoI and ligated to pSH317, which had been cut with the same enzymes. Two clones that contained a divIVA promoter insert of the right size were isolated, but DNA sequencing revealed single mutations in the RBS (P divIVA1 on pSH320). In order to correct this, QuikChange mutagenesis with primers SHW357/SHW358 was employed on pSH320, and several plasmid clones were isolated and transformed to B. subtilis. From these transformations, only three plasmid clones conferred the typical fluorescence pattern of MinJ-GFP on cells of B. subtilis. When sequenced, one of these clones had a corrected RBS but also an unintended G deletion between the RBS and the MinJ-GFP start codon (P divIVA3 ). This clone was named pSH328 and used for all further studies.
Construction of point mutations and C-terminal truncations in divIVA. For the construction of plasmid pINC12 encoding the divIVAR131A gene (where divIVAR131A represents the R-to-A change at position 131 encoded by divIVA) under the control of the P spac promoter, we made use of plasmid pINC3, which already contained the divIVAR131A-gfp allele. pINC3 was originally obtained by QuikChange mutagenesis using the mutagenesis primers R131A_fw/R131A_rev on plasmid pDG9. divIVAR131A of pINC3 was then amplified using the primers SV123/SV81, and the resulting PCR fragment was cut with BamHI/SalI and ligated to the BamHI/SalI-cut vector backbone of plasmid pAPNC213. The DNA sequence of one clone was verified, and this clone was named pINC12. The R102K, R102E, and ⌬C34 (deletion of the C-terminal 34 amino acid residues) mutations were introduced into plasmid pSH2 by QuikChange mutagenesis using the oligonucleotides SHW378/SHW379 (pSH330), SHW380/SHW381 (pSH331), and SHW386/SHW387 (pSH334), respectively. In order to exchange the spc marker for a cat cassette in these plasmids, the KpnI/SacI P spac -divIVA fragments of pSH2, pSH330, pSH331, and pSH334 were then subcloned into the KpnI/SacI-cut backbone of pAPNC213cat in a second step. The resulting plasmids were sequenced and named pSH335 (wild type [wt]), pSH336 (R102K), pSH337 (R102E), and pSH340 (⌬C34).
Strain construction. Plasmids designed for the expression of divIVA alleles in B. subtilis were inserted into the amyE gene of B. subtilis 168, and amylase-negative transformants were selected on the basis of iodine staining of starch-containing agar plates. Alternatively, the aprE locus was also used for chromosomal integrations. Insertions at aprE were generally confirmed by PCR. Combinations of alleles were generated by transformation (27) .
Bacterial two-hybrid analysis. In order to investigate the interaction of the DivIVA and C-terminally truncated DivIVA proteins with MinJ and RacA, the bacterial two-hybrid system was used (28) . Plasmids encoding divIVA alleles fused to the T18 or the T25 fragment of the Bordetella pertussis adenylate cyclase were cotransformed in E. coli BTH101 along with plasmids encoding T25 and T18 fusions to RacA and MinJ. Transformants were selected on nutrient agar plates containing ampicillin (100 g/ml), kanamycin (50 g/ml), X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside; 0.004%), and IPTG (0.1 mM), and photographs were taken after 40 h of growth at 30°C. SHW109  CTTAGGTACCAAGCTAGTAACTATGGTAGAATG  SHW110  GCGCTCGAGTTAACGTTCTTCAGATTCAGCTG  SHW111  GCGCTCGAGACGTTCTTCAGATTCAGCTG  SHW180  CGAAGTAAATGACTTCCTCGATC  SHW184  CTTAACTAGTTTTGTATAGTTCATCCATGCC  SHW237  GAACGTTTAGGTCATTTTACAAACATTGAGGAGA  CATTGAATAAATC  SHW238  GTGGAAGCACAAATGGATTTAATTAAAAATGACG  ATTGGGATCATC  SHW247  CGTCAATCCAAAGTATTCCGTACACGTTTCCAAA  TGCTGATTG  SHW265  CAAACAGCTGCCGAAGAAGTGAAACGCAATTCTC  AAAAAGAAGCAAAG  SHW266  GCAGAAAAAAATGCTGACCGAATTATCAACGAAT  CGTTATCAAAATC  SHW304  AAAGGAAGGACTTGATATCGAATTCC  SHW305  TATCAAGTCCTTCCTTTTCCTCAAATAC  SHW342  ATATGTCGACACATAAAATGCATCTAGAAAGGAG  SHW343  GCGCGGATCCTTATTTGTATAGTTCATCCATGCC  SHW349  TTGCGCTCACATCAAATCGTCTCCCTCCG  SHW350  GATTTGATGTGAGCGCAACGCAAGCTTC  SHW354  GTCGTATGGAGGTGCTAGATATGCCATTAACGCC  AAATGATATTC  SHW355  GTTTCTTCAATGTTTGTAAAATGACCGATTCTTT  CATCAAGCTCATTG  SHW356  GACACCTCGAGCATGATGCCACCTCCATTTTTAC  SHW357  TGATGCCACCTCCATTTTTACATTTC  SHW358  AAATGGAGGTGGCATCATGCTCGAGG  SHW366  GAAGAACGTGGACTCGAGGTCGACGGTATC  SHW367  GACCTCGAGTCCACGTTCTTCAGATTCAGCTG  SHW378  CGCTGATAAAATTATCAACGAATCG  SHW379  GATAATTTTATCAGCGTTTTTCTCC  SHW380  CGCTGATGAAATTATCAACGAATC  SHW381  GATAATTTCATCAGCGTTTTTCTCC  SHW386  TCAGAACATAATTCCAAATGCTGATTGAAG  SHW387  ATTTGGAATTATGTTCTGAACACTTTAGAC  SHW425  CACAATCTAAACTTTCCAAAGATCCCAACG  SHW426  GGAAAGTTTAGATTGTGTGGACAGGTAATG  SV23  GAAAAGGAATAACTTGATATCGAATTC  SV24  GATATCAAGTTATTCCTTTTCCTCAAATAC  SV81  CGCGCGAGCTCTTATTCCTTTTCCTCAAATACAGC  SV98  CTTAGGTACCTTGGCCGGTGCAGCTTAAC  SV123 CGGGATCCAAAATGGAGGTGGCATCATGCCATTA ACGCCAAATG R131A_fw TCAGAACAGCTTTCCAAATGCTGATTG R131A_rev TTTGGAAAGCTGTTCTGAACACTTTAG Microscopic techniques. For microscopy of bacterial cells, a small volume (0.3 l) of an exponentially growing culture was mounted on a microscope slide covered with a thin film of 1.5% agarose (dissolved in distilled water). Membranes were stained using FM5-95. Images were taken with a Nikon Eclipse Ti microscope coupled to a Nikon DS-MBWc charge-coupled-device camera and processed using the NIS elements AR software package (Nikon).
Sporulation assays. B. subtilis strains were streaked on Schaeffer=s sporulation agar (29) containing 0.5% xylose or 1 mM IPTG and incubated for up to 7 days at 37°C, until lysis of the translucent sporulationdeficient strains could be comfortably discriminated from the optically dense appearance of sporulation-proficient strains. Plates were photographed against a black background.
Isolation of cellular proteins, PAGE techniques, and Western blotting. Exponentially growing cells of B. subtilis were harvested by centrifugation (13,000 rpm for 1 min in an Eppendorf 5415R tabletop centrifuge), and the cell pellet was washed once in ZAP buffer (10 mM Tris-HCl, pH 7.5, 200 mM NaCl). Cells were disrupted by sonication in ZAP buffer containing 1 mM phenylmethylsulfonyl fluoride, and cell debris was pelleted in another centrifuge run. Aliquots of the resulting supernatant were separated either by SDS-PAGE or by blue native PAGE, which was performed using NativePAGE Novex 4 to 16% bis-Tris gels (Invitrogen) and carried out according to the instructions given by the manufacturer. Subsequently, gels were blotted onto a polyvinylidene difluoride (PVDF) membrane employing a semidry electroblotting unit. Proteins of interest were visualized using polyclonal rabbit antisera recognizing DivIVA (5) or GFP (lab stock) as the primary antibodies and an antirabbit immunoglobulin G conjugated to horseradish peroxidase as the secondary one. An ECL chemiluminescence detection kit (Thermo Scientific) was then used for the detection of the peroxidase conjugates on the PVDF membranes.
RESULTS

C-terminal DivIVA truncations interfere with MinJ and RacA binding. The tetramerization domain of B. subtilis
DivIVA is followed by 11 nonconserved amino acid residues. The atomic structure of this C-terminal stretch could not be solved using crystallography, suggesting that it is a flexible tail. To determine whether this C-terminal tail is involved in the binding of MinJ and/or RacA, we made use of the bacterial two-hybrid assay and cloned two DivIVA truncations in this system: DivIVA⌬11, which lacks the last 11 C-terminal amino acids, and DivIVA⌬20, which lacks the last 20 C-terminal amino acids, including a part of the tetramerization domain (Table 3 ). Both truncations were still able to interact with full-length DivIVA, indicating that both mutants are expressed normally and can form dimers (Table 3 ; a colored image of the bacterial two-hybrid plate is available in Fig. S1 in the supplemental material). MinJ interacted strongly with full-length DivIVA and with both DivIVA truncations in the bacterial twohybrid assay, whereas RacA showed a weak interaction with fulllength DivIVA that was abolished when the last 11 amino acids of DivIVA were removed (Table 3 ; see Fig. S1 in the supplemental material). It seems that the RacA-DivIVA interaction depends on the 11 C-terminal amino acids of DivIVA, whereas the MinJ contact site is located more to the N terminus of DivIVA. To test this, additional DivIVA truncations were constructed: DivIVA⌬21, DivIVA⌬26, and DivIVA⌬34. These truncations successively removed the complete tetramerization domain. The last two truncations, DivIVA⌬26 and DivIVA⌬34, were severely impaired in their ability to interact with MinJ (Table 3 ; see Fig. S1 in the supplemental material), suggesting that the tetramerization domain contains residues required for MinJ binding.
Importance of the tetramerization domain for DivIVA activity. The bacterial two-hybrid assay also revealed a weakened interaction of the DivIVA⌬26 (corresponding to DivIVA amino acids 1 to 138) and DivIVA⌬34 (corresponding to DivIVA amino acids 1 to 130) truncations with full-length DivIVA, whereas the DivIVA⌬21 truncation (corresponding to DivIVA amino acids 1 to 143) still behaved normally (Table 3 ; see Fig. S1 in the supplemental material). So far there is no biochemical corroboration that amino acids 130 to 143 are involved in tetramerization in vivo. Own preliminary alanine mutagenesis experiments in this region identified R131 as an essential residue for DivIVA activity (see Fig.  S3A to C in the supplemental material), suggesting a special importance of this region for DivIVA function. Thus, DivIVA⌬C34 was expressed in a ⌬divIVA mutant (strain BSN360), and phenotypic analysis of this strain clearly demonstrated the inability of the divIVA⌬C34 allele to complement the cell division and the sporulation phenotype of the ⌬divIVA mutation ( Fig. 2A and B) , even though DivIVA⌬C34 was clearly expressed (Fig. 2C, top) . Blue native PAGE of strain BSN356 expressing wild-type DivIVA showed that DivIVA exists in two different oligomeric states since two signals of different molecular masses were detected by the DivIVA antiserum (Fig. 2C, bottom) . The molecular masses were calculated to be 159 Ϯ 8 kDa for the upper signal and 41 Ϯ 13 kDa for the lower signal in the wild-type cell extract. Given the molecular mass of B. subtilis DivIVA (19.34 kDa), these molecular masses correspond to an octamer and a dimer, respectively. Blue native PAGE of strain BSN360 revealed the existence of a dimer signal (Fig. 2C, bottom) . Previous gel filtration analyses have indicated that purified DivIVA forms octamers and higher-order structures (18, 30) . Therefore, it seems plausible that the region beyond residue 130 indeed contains the tetramerization domain and that tetramerization is a prerequisite step for octamerization. Domain swapping to identify DivIVA interaction domains. It is possible that the C-terminal truncations used in the bacterial two-hybrid system result in misfolded and/or unstable DivIVA variants. This complicates the interpretation of the bacterial twohybrid data. Because of this, we changed tactics and explored the possibility to swap domains between B. subtilis DivIVA and the closely homologous DivIVA from L. monocytogenes. In a previous study, we have shown that L. monocytogenes DivIVA displays the same localization pattern as B. subtilis DivIVA and is involved in SecA2-dependent protein secretion (10) . L. monocytogenes does not sporulate and does not contain a RacA homologue. It is also unlikely that L. monocytogenes DivIVA interacts with MinJ, since deletion of the divIVA gene does not result in a minicell phenotype in L. monocytogenes, indicating that the listerial division site control system is DivIVA independent (10) . This would enable us to separate the DivIVA domains required for localization and for RacA and MinJ interaction. First, it was necessary to confirm that L. monocytogenes DivIVA is normally localized when expressed in B. subtilis. Indeed, L. monocytogenes DivIVA fused to GFP and when expressed in a divIVA-knockout background (strain BSN373) showed a localization pattern that was similar to that of B. subtilis DivIVA (Fig. 3) , even though L. monocytogenes DivIVA predominately exists as a dimer and just to a minor extent in an oligomeric form when expressed in B. subtilis (see Fig. S2 in the supplemental material). More importantly, however, L. monocytogenes DivIVA does not complement the cell division and sporulation defects of a B. subtilis ⌬divIVA mutant (strain BSN238; see Fig. 5A and B) . Thus, L. monocytogenes DivIVA seems to be unable to bind MinJ and RacA and is therefore well suited for domain swapping.
The most prominent difference between L. monocytogenes and B. subtilis DivIVA is found in the C-terminal tail (Fig. 4A) , which is 11 amino acids longer in the L. monocytogenes protein and which has been shown to be important for binding RacA, according to the bacterial two-hybrid data. To test this, a DivIVA chimera was constructed by replacing the last 32 amino acids of L. monocytogenes DivIVA with the last 21 amino acids of B. subtilis DivIVA (Lm-144-Bs DivIVA [144 N-terminal amino acid residues of L. monocytogenes DivIVA fused to the corresponding C-terminal part of B. subtilis DivIVA; see Fig. 4A ]), so that the C-terminal tails were exchanged between both proteins, whereas the core tetramerization domain (amino acids 130 to 143) was left intact (Fig. 4B ). Expression of this chimera in a B. subtilis ⌬divIVA background (strain BSN274) did not restore either cell division or sporulation ( Fig. 5A and B) . Western blotting showed that Lm-144-Bs DivIVA was stably expressed and not degraded (Fig. 4C) . The chimeric protein localized normally, as a GFP fusion indicated (strain BSN295; see Fig. S4 in the supplemental material) and formed a stable oligomer (see Fig. S2 in the supplemental material), suggesting that the last 21 amino acids of B. subtilis DivIVA alone are insufficient for binding of MinJ or RacA.
Systematic domain swapping. Since MinJ and RacA binding seems to require a larger part of B. subtilis DivIVA, we constructed a set of chimeric DivIVA proteins in which the fusion point between the N-terminal L. monocytogenes and the C-terminal B. subtilis parts was shifted from the tail region toward the N terminus of the C-terminal domain in a stepwise fashion, as schematically indicated in Fig. 4B . Position 130 exchanged the complete C terminus beginning from the TD, positions 104 and 83 mark the beginning of short stretches in the coiled-coil region at which both proteins differ at three to four consecutive amino acid positions, whereas the domain swap at position 71 exchanged the complete C-terminal domain behind the flexible linker ( Fig. 4A and B ).
Stability and oligomerization of the chimeras was checked by Western blotting, indicating that all the chimeric DivIVA proteins were expressed at comparable levels ( Fig. 4C ) and were oligomeric (see Fig. S2 in the supplemental material). Expression of these chimeras in the B. subtilis ⌬divIVA background did not restore normal vegetative cell division ( Fig. 5A ), suggesting that they were unable to recruit MinJ. Of the different chimeras, only the Lm-104-Bs DivIVA chimera was able to restore spore formation. To confirm that the Lm-104-Bs DivIVA chimera was indeed able to recruit RacA and not MinJ, the chimera was expressed in ⌬divIVA mutant strains containing either the GFP-RacA or the MinJ-GFP reporter. As shown in Fig. 6A and B , the Lm-104-Bs DivIVA chimera can recruit RacA but not MinJ. In conclusion, the RacA interaction domain resides in the last 60 amino acids of DivIVA and requires residues in the coiled-coil region beyond amino acid 104.
It is surprising that larger replacements of the C terminus (as in Lm-71-Bs and Lm-83-Bs) were again unable to restore sporulation. A possibility is that these chimeras did not localize properly anymore. To test this, we expressed C-terminal GFP fusions to the chimeric DivIVA constructs and analyzed their localization in B. subtilis ⌬divIVA cells. Expression of all DivIVA-GFP proteins gave rise to polar and septal fluorescence signals; however, these signals occurred to different degrees (see Fig. S4A in the supplemental material). While DivIVA Lm-144-Bs -GFP and DivIVA Lm-130-Bs -GFP clearly accumulated at the division septa, the septal fluorescence signals of DivIVA Lm-104-Bs -GFP, DivIVA Lm-83-Bs -GFP, and DivIVA Lm-71-Bs -GFP were less intense but still visible (see Fig.  S4A in the supplemental material). This suggests that all DivIVA chimeras are functional in terms of lipid binding and membrane curvature sensing.
The lipid binding domain recruits MinJ. As none of the chimeras was able to complement the cell division phenotype, it may be that regions in the N-terminal domain are critical for the interaction of B. subtilis DivIVA with MinJ. To test this, we fused the N-terminal 57 amino acids of B. subtilis DivIVA spanning the entire lipid binding domain to the complete C-terminal domain of L. monocytogenes DivIVA (Fig. 4B ). When this DivIVA chimera was expressed in a ⌬divIVA background (strain BSN321), short cells and no minicells were observed (Fig. 5A) , indicating that the Bs-57-Lm DivIVA protein recruits MinJ. The localization as well as oligomerization of this chimera is comparable to that of wildtype DivIVA (see Fig. S4 and Fig. S2 in the supplemental material, respectively) and indeed restores normal septal and polar localization of GFP-MinJ (Fig. 6A ). Strikingly, sporulation was still defective in strain BSN321 (Fig. 5B ) and the Bs-57-Lm chimera was unable to recruit RacA (Fig. 6B ). In conclusion, the lipid binding N-terminal domain of DivIVA contains the MinJ binding site, whereas the C-terminal coiled-coil domain contains the binding site for RacA. DivIVA. This was unexpected since it was assumed that the C-terminal domain would constitute the protein recruitment module for both proteins, with the LBD being important only for dimerization and lipid binding. However, a dual function of the lipid binding domain is in good agreement with the two-domain nature of DivIVA proteins. The lipid binding domain is in close contact with the cytoplasmic membrane and even partially inserts into it, which makes it a good candidate for interacting with transmembrane proteins like MinJ. Since most sequence differences between the LBDs of B. subtilis and L. monocytogenes DivIVA cluster between residues E28 and I57 (Fig. 4A ), this region most likely represents the MinJ binding surface of DivIVA. Support for this assumption comes from the observation that a replacement of the region from amino acids 1 to 16 of Corynebacterium glutamicum DivIVA by the corresponding region from B. subtilis DivIVA was without effect (19) . Lipid binding of DivIVA via its N-terminal domain would in turn leave the C terminus free to reach into the cytoplasm. Fitting with this, our experiments indicated that the C-terminal domain is the interaction module for RacA, which is a soluble cytoplasmic protein. It was recently reported that the interaction of C. glutamicum ParB, which is a chromosome-binding protein like RacA, with its cognate DivIVA requires central regions of the C-terminal domain as well (9) . Our results thus confirm earlier speculations that the sporulation and the division functions of DivIVA can be separated. This had been concluded from the observation that a divIVA mutation consisting of an N-to-D change at position 99 severely affected sporulation but not division (31) . Another classical divIVA point mutation is the divIVA1 mutation in which the alanine at position 78 is replaced by a threonine. This mutation causes a Div Ϫ Spo Ϫ phenotype (32) , even though it lies outside the RacA and MinJ binding regions. Neither expression nor oligomerization of DivIVA is impaired by this mutation (33) . Thus, the A78T exchange might possibly affect subcellular localization of DivIVA or induce structural changes in the protein that reduce its activity but do not influence formation of oligomers.
DISCUSSION
The question that we cannot answer conclusively is, why do the two chimeras with the more N-terminally located fusion points (Lm-83-Bs and Lm-71-Bs) not behave similarly to the Lm-104-Bs DivIVA protein? Initially, this conflicted with the idea that the C-terminal domain is the protein recruitment module for RacA, since C-terminal exchanges longer than those in Lm-104-Bs should result at least in the same degree of complementation activity. We do not think that this is explained by misfolding of the respective chimeric proteins, since they still oligomerize (see Fig.  S2 in the supplemental material) and because GFP-tagged versions of these chimeras still localized to the septum to the same degree as the Lm-104-Bs GFP fusion protein (see Fig. S4A in the supplemental material) and therefore appeared to be folded properly. Moreover, a strain expressing an Lm-57-Bs DivIVA protein showed the same sporulation defect as strains expressing Lm-83-Bs and Lm-71-Bs DivIVA chimeras (data not shown). Possibly, longer C-terminal exchanges do not function in the context of an unrelated lipid binding domain. With regard to this issue, the fact that the arginine 102 residue of B. subtilis DivIVA is phosphorylated might be of special interest here (34) . This phosphorylation could be critical for RacA recruitment and may add an extra dimension of activity control on the different DivIVA chimeras. Therefore, we constructed a phosphoablative (R102K) and a phosphomimetic (R102E) mutant allele of divIVA and tested their activity in our complementation system. Both of these mutations cause a Div ϩ Spo Ϫ phenotype (see Fig. S5 in the supplemental material). Hence, arginine 102 might indeed have a crucial function in RacA binding, but it is not relevant for the interaction with MinJ. Phosphorylations at the C-terminal domains are well described for DivIVA from Mycobacterium tuberculosis (named Wag31 in mycobacteria) and Streptococcus pneumoniae, even though they both occurred at threonine side chains (T73 and T201, respectively). Phenotypic analysis of phosphomimetic and phosphoablative divIVA mutant strains in these organisms also revealed that these phosphorylations are indeed involved in cell shape control (35, 36) . In the future it will be interesting to address showing the ability of the tested L. monocytogenes and B. subtilis DivIVA chimeras to complement the filamentous ⌬divIVA phenotype. Cells were cultivated in LB broth containing 0.5% xylose until mid-log growth phase at 37°C before cell morphology was assessed microscopically. Bar, 5 m. (B) Sporulation plate assay to test the activity of the L. monocytogenes and B. subtilis DivIVA chimeras to complement the sporulation defect of the B. subtilis ⌬divIVA mutant. Strains expressing the DivIVA chimeras were streaked on Schaeffer=s sporulation agar containing 0.5% xylose and kept at 37°C until lysis of nonsporulating strains was comfortably distinguishable from the brownish Spo ϩ strains. The wild type, the ⌬divIVA mutant, and strains complemented with either the B. subtilis (BSN51) or the L. monocytogenes (BSN238) divIVA gene were used as controls. Sections: 1, strain 168 (wt); 2, strain 4041 (⌬divIVA); 3, strain BSN51 (B. subtilis divIVA); 4, strain BSN238 (L. monocytogenes divIVA); 5, strain BSN274 (Lm-144-Bs divIVA); 6, strain BSN278 (Lm-130-Bs divIVA); 7, strain BSN288 (Lm-104-Bs divIVA); 8, strain BSN287 (Lm-83-Bs divIVA); 9, strain BSN316 (Lm-71-Bs divIVA); 10, strain BSN321 (Bs-57-Lm divIVA). Note that sporulation of strain BSN288 (Lm-104-Bs divIVA) did not reach the wild-type level. This might be explained by the lack of MinCD activity in this strain, which is required for full sporulation (37) . the regulatory impact of such phosphorylations for DivIVA binding partner recruitment.
